Tetrabutylammonium fluoride solution

• Catalog No.: 86923
• CAS Number: 429-41-4
• M. F.: C16H36FN
• M. W.: 261.4621432

SYNONYMS

• Title: 四丁基氟化铵 溶液
• IUPAC name: tetrabutylazanium fluoride
• IUPAC Traditional name: tetrabutylammonium fluoride
• Synonyms: TBAF solution; TBAF 溶液

DATABASE IDS

• MDL Number: MFCD00011747
• Beilstein Number: 3762762
• CAS Number: 429-41-4

PROPERTIES

• Concentration: ~75% in H2O (NT)
• Grade: purum
• Linear Formula: [CH3(CH2)3]4NF
• Refractive Index: n20/D 1.456
• GHS Signal Word: Danger
• GHS Hazard statements: H314
• European Hazard Symbols: Corrosive (C)
• Personal Protective Equipment: Faceshields, full-face respirator (US), Gloves, Goggles, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
• GHS Precautionary statements: P280-P305 + P351 + P338-P310
• RID/ADR: UN 1760 8/PG 2
• Risk Statements: 34
• Safety Statements: 26-36/37/39-45
• Hazard Class: 8
• UN Number: 1760
• Packing Group: 2
• German water hazard class: 3

DETAILS

Description (English)

Application
Reactant for preparation of:
• Triple monoamine reuptake inhibitors as a new generation of antidepressants1
• Alcohols via hydrolysis of alkyl silyl ethers neutral pH in mixed organic-aqueous buffered solutions2
• Oligoribonucleotides with phosphonate-modified linkages3
• Aryl alkyl alcohols via Nozaki-Hiyama allylation catalyzed by chiral bipyridyldiol ligands and chromium trichloride4
• Conjugated dienoic acid esters using Suzuki coupling reactions5
• Macrocyclic o-aminobenzamide Hsp90 inhibitorwith antitumor activity6
• Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors7
• Anti-diabetic polyacetylenic glucosides8

Description (简体中文)

Application
Reactant for preparation of:
• Triple monoamine reuptake inhibitors as a new generation of antidepressants1
• Alcohols via hydrolysis of alkyl silyl ethers neutral pH in mixed organic-aqueous buffered solutions2
• Oligoribonucleotides with phosphonate-modified linkages3
• Aryl alkyl alcohols via Nozaki-Hiyama allylation catalyzed by chiral bipyridyldiol ligands and chromium trichloride4
• Conjugated dienoic acid esters using Suzuki coupling reactions5
• Macrocyclic o-aminobenzamide Hsp90 inhibitorwith antitumor activity6
• Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors7
• Anti-diabetic polyacetylenic glucosides8